Received Sep 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 4SB5S | SC |
Dose administered after a temperature excursion; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a male patient who received MMR (Priorix) (batch number 4SB5S, expiry date 01-MAR-2027) for prophylaxis. On 11-AUG-2025, the patient received Priorix (subcutaneous). On an unknown date, an unknown time after receiving Priorix, the patient experienced incorrect storage of drug (Verbatim: Dose administered after a temperature excursion). The outcome of the incorrect storage of drug was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 20-AUG-2025 Reporter stated that one patient received Priorix after the vaccine was stored in the freezer at a lowest temperature of minus 20 degree Celsius, which led to incorrect of storage of drug. Also stated that the vaccine was thawed before it was administered.